JPMorgan Chase ends the week with a small wrinkle in an otherwise clean story: short interest has ticked up and borrow costs have spiked, yet the underlying conviction from the Street and the lending market's sheer depth together keep the setup firmly constructive ahead of October 13 earnings.
The most notable move this week is in cost to borrow, which has nearly doubled from 0.26% to 0.47% — up 25% on the week and 74% over the past month. That sounds dramatic in percentage terms. In absolute terms it remains trivially cheap. The borrow market itself is essentially inexhaustible: availability is running at 9,999% of short interest, meaning there are roughly 1.45 billion shares available to lend against fewer than 27 million currently borrowed. Short interest has edged up about 4.5% on the week to 0.98% of the free float — marginally back above the 1% threshold that the prior note flagged as the key level, though still the lowest reading among mega-cap US banks. The ORTEX short score has crept to 31.3, its highest reading in the recent window, though the move is small. Nothing here reads as a conviction short-build; it looks more like routine repositioning into the October catalyst. Options confirm that reading: the put/call ratio is 1.13, almost exactly in line with its 20-day average of 1.14, with a z-score of -0.20. Hedging demand is neither elevated nor retreating.
The Street's direction of travel is unambiguous, even if the bull-bear spread on targets remains wide. Since the Q2 print on July 14 — when the stock gained 3.7% in a single session and held most of that into the week — virtually every analyst who touched the name raised their target. Wells Fargo's Mike Mayo lifted his target to $390 in mid-August. UBS moved to $400 in early August. BofA Securities pushed to $420, and Barclays matched that level after the Q2 report. The bears among the consensus — Truist sits at $352, Baird at $305, Citigroup at $360 — have also raised targets, just not by as much. The consensus target of $376 implies roughly 6% upside from the current $356.23. Factor scores add texture: EPS surprise ranks in the 92nd percentile of the universe, and EPS momentum over the past 90 days ranks in the 90th — JPM has been consistently beating estimates and the trend in estimate revisions has been upward. The dividend score at the 94th percentile reflects the strength of the capital return programme. The one softer read is near-term EPS momentum (30-day, 24th percentile), suggesting the pace of upward revisions has moderated recently.
Insider activity adds little to the week's story. The only open-market transaction in the recent filing record is a planned sale by Head of Human Resources Robin Leopold — 2,500 shares at $352.81 on September 10, executed under a pre-arranged 10b5-1 plan. Pre-planned sales are compensation mechanics, not signals of conviction, and the size is immaterial relative to the float. The June-quarter awards to several directors are routine equity compensation. The 90-day net position for insiders is -10,467 shares, overwhelmingly driven by those 10b5-1 sales. No open-market buying has appeared in the filing record over that window.
Among peers, the week has been mixed. Wells Fargo gained 1.2% on the week — the standout in the group. Bank of America was nearly flat at -0.6%. KeyCorp and US Bancorp each fell around 1%, and Popular was the notable laggard, down 4.4%. JPM's own -0.7% on the week sits in the middle of the pack. The relative resilience is consistent with the prior note's observation that JPM carries the lowest short interest in the mega-cap bank group — less mechanical pressure from cover-and-rally dynamics.
The clock now ticking toward Q3 results on October 13 is the frame for everything that follows. The last two earnings prints produced a 3.7% and a 0.4% one-day gain respectively — a pattern that rewarded staying long into the report rather than fading it. The question going into that release is whether the recent deceleration in near-term estimate revisions hardens into a miss, or whether the bank's diversified revenue base again outpaces consensus. The cost-to-borrow move is worth watching for continuation; a further doubling from here would start to say something more meaningful about demand for downside protection, even in a lending pool this deep.
See the live data behind this article on ORTEX.
Open JPM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
